Developing point-of-care CAR T manufacturing
European Pharmaceutical Review
DECEMBER 27, 2023
Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks. 4 Manufacturing of CAR T-cell therapies: an overview In addition, multi-disciplinary teams must be established for in-house CAR T-cell therapy programmes to ensure maximum success and safety.
Let's personalize your content